• AAPL 169.3
  • TSLA 168.29
  • AMZN 179.62
  • MSFT 406.32
  • INTC 31.88
  • EURUSD 1.0699
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TA /
  3. BLRX.TA

BioLine RX Ltd (BLRX TA) stock market data APIs

ILA16.3 -0.1(-0.6%) as of April 25, 2024

BioLine RX Ltd Financial Data Overview

16.4
16.3
-
17.2
16.2
16.2-70
204 M
1 199 M
4 800 K
-0.04
0.927
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BLRX',
Type: 'Common Stock',
Name: 'BioLine RX Ltd',
Exchange: 'TA',
CurrencyCode: 'ILA',
CurrencyName: 'Israeli Agora',
CurrencySymbol: 'ILA',
CountryName: 'Israel',
CountryISO: 'Il',
OpenFigi: NULL,
ISIN: 'IL0011015182',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2011-07-25',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

BioLine RX Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 800 K
  • EBITDA -42 172 000
  • Earnings Per Share -0.22
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get BioLine RX Ltd Earnings via APIs

  • Latest Release 2018-08-14
  • EPS/Forecast NaN

Get BioLine RX Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get BioLine RX Ltd latest news via APIs

3 Smart Penny Stocks with Huge Potential

When it comes to investing in top penny stocks, a word of caution. Do your due diligence before buying. Make sure it has volume. And know upfront that you can lose a lot of money. Sure, some penny ...

BioLineRx Announces Initiation of Randomized Phase 2 Clinical Trial in First Line Metastatic Pancreatic Cancer Based on Preliminary Data from Single-Arm Pilot Phase; Combination Trial Includes Investigational Candidate Motixafortide

TEL AVIV, Israel, July 17, 2023 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial stage biopharmaceutical company pursuing life-changing therapies for certain cancers and r...
Do you have any questions?
support@eodhistoricaldata.com